Answers are grounded in this paper and cite their sources.
Experimental in vitro and in silico study shows exosomes' antibacterial potential against Clostridium perfringens, suggesting therapeutic uses.
Background: protein-protein docking. Methods: enzymes using ClusPro. OD600 values were compared across exosome concentrations using one-way analysis of variance (ANOVA) (P<0.05). Results: RNA polymerase and ATP synthase, and between cathelicidin and DNA gyrase, with lower but consistent docking scores for Annexin A1 across targets. Conclusion: interactions with key bacterial enzymes.
No takes yet. Share an insight, caveat, or question.
Banafi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: